The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| SCL | -35.46% | -56.39% | -15.29% | +32,273% |
| S&P | +15.06% | +95.03% | +14.29% | +6,908% |
Stepan Co. engages in the manufacture and sale of specialty and intermediate chemicals. It operates through the following segments: Surfactants, Polymers, and Specialty Products. The Surfactants segment offers a range of surfactant chemicals such as anionic, cationic, nonionic, and amphoteric surfactants. The Polymers segment produces polyester polyols and phthalic anhydride. The Specialty Products segment consists of chemicals used in food, flavoring, nutritional supplements, and pharmaceutical applications. The company was founded by Alfred C. Stepan Jr. in 1932 and is headquartered in Northbrook, IL.
Get a list of current -- and potential future -- Dividend Kings and learn how to leverage these strong companies to build wealth.
Specialty chemical maker Stepan posted strong Q1 results as it offset a 4% drop in sales volume with higher prices on its products.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $594.69M | 6.9% |
| Gross Profit | $71.88M | 3.4% |
| Gross Margin | 12.09% | -0.4% |
| Market Cap | $1.23B | -34.7% |
| Market Cap / Employee | $0.51M | 0.0% |
| Employees | 2.4K | 0.3% |
| Net Income | $11.34M | 19.1% |
| EBITDA | $49.25M | 5.5% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $88.90M | -28.7% |
| Accounts Receivable | $442.15M | 1.1% |
| Inventory | 329.5 | 23.9% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $433.34M | 0.5% |
| Short Term Debt | $289.28M | -2.2% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 2.43% | 1.0% |
| Return On Invested Capital | 6.90% | -1.2% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$14.41M | -6825.5% |
| Operating Free Cash Flow | $11.19M | -62.1% |
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Earnings | 38.66 | 29.46 | 22.45 | 21.55 | -61.08% |
| Price to Book | 1.46 | 1.19 | 1.06 | 1.03 | -33.93% |
| Price to Sales | 0.81 | 0.68 | 0.57 | 0.55 | -36.82% |
| Price to Tangible Book Value | 1.65 | 1.35 | 1.20 | 1.16 | -34.50% |
| Price to Free Cash Flow TTM | 36.23 | 117.25 | 278.28 | - | |
| Enterprise Value to EBITDA | 45.81 | 57.49 | 32.73 | 38.22 | -29.44% |
| Free Cash Flow Yield | 2.8% | 0.9% | 0.4% | - | |
| Return on Equity | 3.8% | 4.2% | 4.7% | 4.8% | 64.90% |
| Total Debt | $758.76M | $698.01M | $731.26M | $722.62M | -0.64% |
SCL earnings call for the period ending September 30, 2021.
SCL earnings call for the period ending June 30, 2021.
SCL earnings call for the period ending March 31, 2021.
SCL earnings call for the period ending December 31, 2020.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
